303 related articles for article (PubMed ID: 37215990)
1. B cells in tumor metastasis: friend or foe?
Xu Y; Mao Y; Lv Y; Tang W; Xu J
Int J Biol Sci; 2023; 19(8):2382-2393. PubMed ID: 37215990
[TBL] [Abstract][Full Text] [Related]
2. External cues to drive B cell function towards immunotherapy.
Stoycheva D; Simsek H; Weber W; Hauser AE; Klotzsch E
Acta Biomater; 2021 Oct; 133():222-230. PubMed ID: 33636402
[TBL] [Abstract][Full Text] [Related]
3. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.
Mukaida N; Nakamoto Y
World J Gastroenterol; 2018 May; 24(17):1839-1858. PubMed ID: 29740200
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of sentinel lymph node microenvironment during tumor metastasis.
Li YL; Hung WC
J Biomed Sci; 2022 Oct; 29(1):84. PubMed ID: 36266717
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
7. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
8. Kras and Tumor Immunity: Friend or Foe?
Cullis J; Das S; Bar-Sagi D
Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29229670
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell biology and its role in tumor immunotherapy.
Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
[TBL] [Abstract][Full Text] [Related]
10. Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Pansy K; Uhl B; Krstic J; Szmyra M; Fechter K; Santiso A; Thüminger L; Greinix H; Kargl J; Prochazka K; Feichtinger J; Deutsch AJ
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948104
[TBL] [Abstract][Full Text] [Related]
11. Metabolic dialogs between B cells and the tumor microenvironment: Implications for anticancer immunity.
Jiang S; Feng R; Tian Z; Zhou J; Zhang W
Cancer Lett; 2023 Mar; 556():216076. PubMed ID: 36724837
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment.
Ma F; Vayalil J; Lee G; Wang Y; Peng G
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642246
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
14. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
15. Exploiting autophagy-regulative nanomaterials for activation of dendritic cells enables reinforced cancer immunotherapy.
Guan YH; Wang N; Deng ZW; Chen XG; Liu Y
Biomaterials; 2022 Mar; 282():121434. PubMed ID: 35202930
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer.
Rogers T; DeBerardinis RJ
Trends Cancer; 2021 Aug; 7(8):700-713. PubMed ID: 34023325
[TBL] [Abstract][Full Text] [Related]
17. Differentiation and Regulation of T
Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
Front Immunol; 2021; 12():669474. PubMed ID: 34012451
[TBL] [Abstract][Full Text] [Related]
18. An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Morishita Y; Kashiwabara K; Takazawa M; Ohara O; Kakimi K; Nakajima J
J Thorac Oncol; 2017 May; 12(5):791-803. PubMed ID: 28088513
[TBL] [Abstract][Full Text] [Related]
19. Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity.
Qin Y; Lu F; Lyu K; Chang AE; Li Q
Front Immunol; 2022; 13():881427. PubMed ID: 35967441
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
